Agenda


The following is the agenda for ChinaBio® Investor Forum 2012-Beijing. (Updated on August 28, 2012)

ChinaBio Investor Forum 2012-Beijing - Detailed Agenda

Tuesday, September 4, 2012

17:30 - 19:30

Welcome Reception
Meet with speakers and other attendees at this informal reception

?

Day 1 - Wednesday, September 5, 2012

Time

Title/Description

Speakers

08:00 - 09:00

Registration and Refreshments

?

09:00 - 09:30

Welcome Remarks

Greg B. Scott - President & Founder, ChinaBio® LLC

Jiantao He - Vice Director, Daxing Bio-medicine Industry Park

Marko Vänskä - CEO, China-Finland Golden Bridge

09:30 - 10:00

Keynote 1: The State of China Life Science: From Local to Global

As China's life science industry continues to lead the world in growth, it is quickly evolving from a local market to having global impact. Innovation is now being created inside of China at the same time international companies are bringing innovation to China. This has stimulated VC investment, M&A and IPO activity in China, and driven partnering and corporate investment to new heights. Mr. Scott will present recent data on the industry, highlighting areas of significant opportunity in China.

Greg B. Scott - President & Founder, ChinaBio® LLC

10:00 - 10:30

Keynote 2: BioFinland Investment Opportunities

A strong combination of science and technological expertise makes Finland one of the most competitive nations in the world in biotechnology and healthcare. Finnish life science companies are now entering the Chinese market and investors are seeking leading technologies to bring to China, making a good match. Dr. Reijonen will provide insights on the biotech industry and innovation in Finland, and which technology trends Chinese investors should keep their eye on.

Kalevi Reijonen, PhD - Board Member, Finnish Biotech Association

10:30 - 11:00

Networking Break and Refreshments

?

11:00 - 12:00

Session 1: VC Funding in China: Alive and Well

While the US and Europe are facing a significant drought in funding available for life science companies, VC funding in China remains alive and well. Many international as well as domestic investment firms are seeking mid- and late-stage investments as well as early stage companies offering novel technologies addressing significant markets. Hear from a group of seasoned VCs managing major funds focused on the China life science industry.

Moderator:
Marc A. Schueler, MD, PhD, MBA - Senior Advisor, CW Downer

Panelists:
Min Cui, PhD - Managing Director, Decheng Capital

Karen Liu, PhD, EMBA - Partner, Kaiwu Capital

Yi Shi, PhD, MBA - Managing Director, Lilly Asian Ventures

Xiangyu Ouyang, EMBA - Managing Director, Legend Capital

Jonathan Wang, PhD, MBA - Senior Managing Director, OrbiMed

12:00 - 13:30

Luncheon

?

13:30 - 15:00

Company Presentations

?

15:00 - 17:00

VC Breakout Meetings 

?

17:00 - 18:30

Beijing Daxing Life Science Park Tour
Daxing is a prime location for life science companies in China, offering a variety of incentives and support services.

?

18:30 - 20:30

Gala Banquet
Join us at the beautiful Roaring Dragon Pavilion for a dinner fit for the royal family of the Qing Dynasty.

?

Day 2 - Thursday, September 6, 2012

Time

Title/Description

Speakers

08:30 - 09:30

Registration and Refreshments

?

09:30 - 10:30

Session 2: Alternative Funding: Corporate Partnering

Some attractive alternatives to VC money include government and corporate funding. Corporate partnering and investment are increasing rapidly in China, with more deals done in 2011 than ever before. Especially in the pharmaceutical industry, Chinese companies are seeking to build novel product portfolios through in-licensing, co-development, strategic partnerships and equity investments. Learn what some of China's most successful companies are looking for in partnerships.

Moderator:
Sherry Yin - Partner, Morrison & Foerster LLP

Panelists:
Sammy Jiang, MBA - Associate President, Luye Pharma Group Ltd.

Larry Liu - Director, Business Development Department, Beijing Hanmi pharmaceutical

Mike Liu, PhD, MBA - Head of Global Business Development, Jiangsu Hengrui Medicine Co., Ltd.

10:30 - 11:00

Networking Break and Refreshments

?

11:00 - 12:00

Session 3: How to Launch a Company in China

There are many factors to be considered when establishing a successful company in China: corporate structure, location, intellectual property, government relationships, VC funding, and more. This session will guide entrepreneurs in the best way to leverage the many benefits China can offer: funding, government incentives, talent pool, etc.

Greg B. Scott - President & Founder, ChinaBio® LLC

12:00 - 13:30

Luncheon

?

13:30 - 15:00

Company Presentations

?

15:00 - 16:00

VC Breakout Meetings

?

16:00 - 16:30

Raffle Drawings - Win valuable prizes
(Must be present to win)

?

16:30 - 17:00

Award Ceremony / Closing Remarks

?

17:00 - 18:00

Closing Reception

?

 

Organizer

Co-Hosts

Sponsors & Partners

Gold Sponsors
 
Official Partners
 
VC Partners
 
Supporting Partners
 
Media Partners